Ovarian and breast cytotoxic T lymphocytes can recognize peptides from the amino enhancer of split protein of the Notch complex

Molecular Immunology

Volumn 35, Issue 17, 1998, Pages 1121-1133

  Babcock, B ^a   Anderson, B W ^a   Papayannopoulos, I ^b,d   Castilleja, A ^a   Murray, J L ^a   Stifani, S ^c   Kudelka, A P ^a   Wharton, J T ^a   Ioannides, C G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BIOGEN   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d CytoMed Inc   (United States)

Author keywords

AES; Breast; CTL; Epitopes; Notch; Ovary

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; BREAST; CYTOTOXIC T LYMPHOCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; OVARY; PRIORITY JOURNAL; PROTEIN ANALYSIS; TUMOR IMMUNOLOGY;

ANTIGENS, NEOPLASM; BREAST NEOPLASMS; EPITOPES; FEMALE; HUMANS; MASS SPECTROMETRY; MEMBRANE PROTEINS; OVARIAN NEOPLASMS; PEPTIDE FRAGMENTS; PROTEINS; RECEPTORS, NOTCH; REPRESSOR PROTEINS; SEQUENCE ANALYSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032429418     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(98)00100-X     Document Type: Article

References (44)

1. Alexander-Miller, M., Leggatt, G.R., Sarin, A., Berzofsky, J.A., 1996. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J Exp. Med. 184, 485-492.
2. Artavanis-Tsakonas, S., Matsuno, K., Fortini, M.E., 1995. Notch signaling. Science 268, 225-232.
3. Boon, T. van der Bruggen, P., 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183, 725-729.
4. + CTL. J. Exp. Med. 181, 363-368.
5. Cox, A.L., Skipper, J., Chen, Y., Henderson, R.A., Darrow, T.L., Shabanowitz, J., Engelhard, V.H., Hunt, D.F., Slingluff, C.L., 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264, 716-719.
6. den Haan, J.M.M., Sherman, N.E., Bloklan, E., Huczko, E., Koning, F., Drijthout, J.W., Skipper, J., Shabanowitz, J., Hunt, D.F., Engelhard, V.H., Goulmy, E., 1995. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268, 1476-1480.
7. Ellisen, L.W., Bird, J., West, D.C., Soreng, A.L., Reynolds, T. C., Smith, S.D., Sklar, J., 1991. TAN-1, the Human Homolog of the Drosophila Notch Gene, is broken by Chromosomal Translocations in T Lymphoblastic Neoplasms. Cell 66, 649-661.
8. + cytotoxic T lymphocytes. Cancer Res. 57, 87-93.
9. Fisk, B., Blevins, T.L., Wharton, J.T., Ioannides C. G., 1995. Identification of an immunodominat peptide of HER-2/neu proto-oncogene recognized by ovarian tumor specific CTL lines. J. Exp. Med. 181, 2709-2717.
10. Fisk, B., Chesak, B., Pollack, M., Wharton, J.T., Ioannides, C.G., 1994. Oligopeptide induction of a cytotoxic T lymphocyte response to HER-2/neu proto-oncogene in vitro. Cell. Immunol. 157, 412-427.
11. + CTL. International Journal of Oncology 10, 159-169.
12. Fisk, B., Savary, C., Hudson, J.M., O'Brian, C.A., Murray, J.L., Wharton, J.T., Ioannides, C.G., 1996. Changes in a HER-2 peptide up-rcgulaling HLA-A2 expression affect both conformational epitopes and CTL recognition. Implications for optimization of antigen presentation and tumor specific CTL induction. Journal of Immunotherapy 18, 197-209.
13. Houghton, A.N., 1994. Cancer Antigens: Immune recognition of self and altered self. J. Exp. Med. 180, 1-4.
14. Hunt, D.F., Henderson, R.A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A.L., Appella, E., Engelhard, V.H., 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255, 1261-1263.
15. Ioannides, C.G., Fisk, B., Fan, D., Biddison, W.A., Wharton, J.T., O'Brian, C.A., 1993a. Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene. Cell. Immunol. 151, 225-234.
16. Ioannides, C.G., Fisk, B., Jerome, K., Irimura, T., Wharton, J.T., Finn, O.J., 1993b. Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J. Immunol. 151, 3693-3703.
17. Ioannides, C.G., Freedman, R.S., Platsoucas, C.D., Rashed, S., Kim, Y.P., 1991. Cytotoxic T cells clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells. J. Immunol. 146, 1700-1707.
18. Jarriault, S., Brou, C., Logeat, F., Schroeter, E.H., Kopan, R., Israel, A., 1995. Signalling downstream of activated mammalian Notch. Nature 377, 355-318.
19. Jerome, K.R., Domenech, N., Finn, O.J., 1993. Tumor-specific CTL clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin cDNA. J. Immunol. 151, 1653-1662.
20. Kawakami, Y., Eliyahu, S., Delgado, C.H., Robbins, P.F., Sakaguchi, K., Appella, E., Yannelli, J.R., Adema, G.J., Miki, T., Rosenberg, S.A., 1994a. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. U.S.A. 91, 6458-6462.
21. Kawakami, Y., Eliyahu, S., Sakaguchi, S., Sakaguchi, K., Robbins, P.F., Rivoltini, L., Yanelli, E., Appella, E., Rosenberg, S.A., 1994b. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180, 347-352.
22. + T cell clones specific for the HER-2/neu proto-oncogene expressed in ovarian carcinomas: related and unrelated to decreased MHC class I expression. Int. J. Cancer 70, 112-119.
23. Larsson, C., Lardelli, M., White, I., Lendahl U., 1994. The human Notch 1, 2, and 3 genes are located at chromosome positions 9q34. Ip13 p11, and 19p13.2 p13.1 in regions of neoplasia-associated translocation. Genomics. 24 (2), 253-258.
24. Liu Y., Dehni G., Purcell K.J., Sokolow J., Carcangiu M.L., Artavanis-Tsakonas S., Stifani S., 1996. Epithelial expression and chromosomal location of human TLE genes: Implications for notch signaling and neoplasia. Genomics 31, 58-64.
25. Mallo, M., Gendron-Maguire, M., Harbison, M.L., Gridley, T., 1995a. Protein characterization and targeted disruption of Grg, a mouse gene related to the groucho transcript of the Drosophila Enhancer of split complex. Dev. Dynamics 204, 338-347.
26. Mallo, M., Lieberman, PM., Gridley, T., 1995b. Possible involvement of the mouse Grg protein in transcription. Cell. & Molec. Biol. Res. 41, 435-440.
27. Michalek, M.T., Grant, E.P., Gramm, C., Goldberg, A.L., Rock, K.L., 1993. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 363, 552.
28. Miyasaka, H., Choudhury, B.K., Hou, E.W., Li, S.S., 1993. Molecular cloning and expression of mouse and human cDNA encoding AES and ESG proteins with strong similarity to Drosophila enhancer of split groucho proteins. Eur. J. Biochem. 216, 343-352.
29. Palaparti, A., Baratz, A., Stifani, S., 1997. The Groucho/transducin-like enhancer of split transcriptional repressors interact with the genetically defined amino-terminal silencing domain of histone H3. J. Biol. Chem. 272, 26604-26610.
30. Papayannopoulos, I.A., 1995. The interpretation of collision-induced dissociation tandem mass spectra of peptides. Mass Spectometry Reviews 14, 49-73.
31. Pear, W.S., Aster, JC., Scott, M.L., Hasserjian, R.P., Soffer, B., Sklar, J., Baltimore, D., 1996. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J. Exp. Med. 183, 2283-2291.
32. Peoples, G.E., Goedegebuure, P.S., Smith, R., Linehan, D.C., Yoshino, I., Eberlein, T.J., 1995. Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. Proc. Natl. Acad. Sci., U.S.A. 92, 432-436.
33. Rivoltini, L., Barracchini, K.C, Viggiano, V., Kawakami, Y., Smith, A., Mixon, A, Restifo, N.P., Topalian, S.L., Simonis, T.B., Rosenberg, S.A., Marincola, F.M., 1995. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res., 55, 3149-3157.
34. Samson, I., Kerremans, L., Rozenski, J., Samyn, B., Van Beeumen, J., Van Aerschot, A., Herdewijn. P., 1995. Identification of a peptide inhibitor against glycosomal phosphoglycerate kinase of Trypanosoma brucei by a synthetic peptide library approach. Bioorganic and Medicinal Chemistry 3, 257-265.
35. Seung, L.P., Rowley, D.A., Dubey, P., Schreiber, H., 1995. Synergy between T cell immunity and inhibition of paracrine stimulation causes tumor rejection. Proc. Natl. Acad. Sci. U.S.A. 92, 6254-6258.
36. Shirayoshi, Y., Yuasa, Y., Suzuki, T., Sugaya, K., Kawase, E., Ikemura, T., Nakatsuji N., 1997. Proto-oncogene of int-3, a mouse Notch homologue, is expressed in endothelial cells during early embryo-genesis. Genes to Cells 2, 213-224.
37. Slingluff, Jr., C.L., Cox, A.L., Henderson, R.A., Hunt, D.F., Engelhard, V.H., 1993. Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. J. Immunol. 150, 2955-2963.
38. Stifani, S., Blaumueller, C.M., Redhead, N.J., Hill, R.E., Astavanis-Tsakonas, S., 1992. Human homologs of a Drosophila Enhancer of Split gene product define a novel family of nuclear proteins. Nature (Genetics) 2, 119-127.
39. + cytotoxic T lymphocytes in association with a class I MHC protein. Cell 69, 989-998.
40. Varnum-Finney, B., Purton, LE., Yu, M., Brashem-Stein, C., Flowers, D., Staats, S., Moore, KA., Le, Rous I., Mann R., Gray G., 1998. Artavanis-Tsakonas S. Bernstein ID. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood. 91 (11), 4084-4091.
41. Yao, J. Liu, Husain, J., Lo R., Palaparti, A., Henderson, J., Stifani, S., 1998. Combinatorial expression patterns of individual TLE proteins during cell determination and differentiation suggest non-redundant functions for mammalian homologs of Drosophila Groucho. Development Growth & Differentiation 40, 133-146.
42. Yewdell, J.W., Anton, L. C., Bennink, J R., 1996. Defective ribosomal products (DRiPs). A major source of antigenic peptides for MHC class I molecules? J. Immunol. 157, 1823-126.
43. Yoshino, I., Goedegeboure, P.S., Peoples, G.E., Parikh, A.S., DiMain, J.M., Lyerly, H.K., Gazdar, A.F., Eberlein, T.J., 1994. HER2, neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer. Cancer Res. 54, 3387-3390.
44. Zagouras, P., Stifani, S., Blaumueller, C.M., Carcangiu, M.L., Artavanis-Tsakonas, S., 1995. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc. Natl. Acad. Sci. U.S.A. 92, 6414-6418.